Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment <sup>18</sup>F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer.

BMC Cancer · 2025 · PMC11871599 · PMID 40022087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an apparent trendno p-value reported

The DeLong test and McNemar test revealed no significant differences in their AUC, sensitivity, or specificity ( p > 0.05), despite an apparent trend toward differences observed in Fig. 5B.

also in 709 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment &lt;sup&gt;18&lt;/sup&gt;F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer.

The sentences

Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment <sup>18</sup>F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer.